Literature DB >> 4789023

Short-term treatment of patients with chronic and recurrent urinary tract infections with co-trimoxazole.

H J de Voogt, H Mattie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4789023     DOI: 10.1007/bf00256615

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


× No keyword cloud information.
  7 in total

1.  Control of bacteriuria with sulphamethoxazole-trimethoprim in patients with urinary tract obstruction and chronic infection. A preliminary report.

Authors:  M L Nielsen; H Laursen; P Christensen
Journal:  Scand J Urol Nephrol       Date:  1972

2.  Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations with particular reference to the treatment of urinary infections.

Authors:  W Brumfitt; M C Faiers; R E Pursell; D S Reeves; A R Turnbull
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

3.  Combined trimethoprim-sulfisoxazole therapy of urinary infections. Clinical studies.

Authors:  C E Cox; W G Montgomery
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

4.  Long-term control of bacteriuria with trimethoprim-sulphonamide.

Authors:  W R Cattell; D A Chamberlain; I K Fry; M A McSherry; C Broughton; F O'Grady
Journal:  Br Med J       Date:  1971-02-13

5.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

6.  Trimethoprim--sulphamethoxazole: comparative study in urinary infection in hospital.

Authors:  D S Reeves; M C Faiers; R E Pursell; W Brumfitt
Journal:  Br Med J       Date:  1969-03-01

7.  Trimethoprim in the treatment of urinary infections in hospital.

Authors:  R N Grüneberg; R Kolbe
Journal:  Br Med J       Date:  1969-03-01
  7 in total
  1 in total

1.  Single-dose antibiotic treatment: a new approach to lower urinary tract infections in primary care.

Authors:  S Shortt
Journal:  Can Fam Physician       Date:  1981-01       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.